-
Je něco špatně v tomto záznamu ?
Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations
A. Gkourogianni, M. Andrew, L. Tyzinski, M. Crocker, J. Douglas, N. Dunbar, J. Fairchild, MF. Funari, KE. Heath, AA. Jorge, T. Kurtzman, S. LaFranchi, S. Lalani, J. Lebl, Y. Lin, E. Los, D. Newbern, C. Nowak, M. Olson, J. Popovic, Š. Pruhová, L....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie
Grantová podpora
NV16-31211A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Free Medical Journals
od 1997 do Před 1 rokem
PubMed
27870580
DOI
10.1210/jc.2016-3313
Knihovny.cz E-zdroje
- MeSH
- agrekany genetika MeSH
- antropometrie metody MeSH
- brachydaktylie genetika MeSH
- degenerace meziobratlové ploténky genetika MeSH
- dítě MeSH
- dospělí MeSH
- fenotyp MeSH
- heterozygot MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mutace * MeSH
- mutační analýza DNA metody MeSH
- nanismus farmakoterapie genetika MeSH
- osteochondritis dissecans vrozené genetika MeSH
- předškolní dítě MeSH
- rodokmen MeSH
- růst genetika MeSH
- růstový hormon terapeutické užití MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- výhřez meziobratlové ploténky genetika MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
Context: Heterozygous mutations in the aggrecan gene (ACAN) cause autosomal dominant short stature with accelerated skeletal maturation. Objective: We sought to characterize the phenotypic spectrum and response to growth-promoting therapies. Patients and Methods: One hundred three individuals (57 females, 46 males) from 20 families with autosomal dominant short stature and heterozygous ACAN mutations were identified and confirmed using whole-exome sequencing, targeted next-generation sequencing, and/or Sanger sequencing. Clinical information was collected from the medical records. Results: Identified ACAN variants showed perfect cosegregation with phenotype. Adult individuals had mildly disproportionate short stature [median height, -2.8 standard deviation score (SDS); range, -5.9 to -0.9] and a history of early growth cessation. The condition was frequently associated with early-onset osteoarthritis (12 families) and intervertebral disc disease (9 families). No apparent genotype-phenotype correlation was found between the type of ACAN mutation and the presence of joint complaints. Childhood height was less affected (median height, -2.0 SDS; range, -4.2 to -0.6). Most children with ACAN mutations had advanced bone age (bone age - chronologic age; median, +1.3 years; range, +0.0 to +3.7 years). Nineteen individuals had received growth hormone therapy with some evidence of increased growth velocity. Conclusions: Heterozygous ACAN mutations result in a phenotypic spectrum ranging from mild and proportionate short stature to a mild skeletal dysplasia with disproportionate short stature and brachydactyly. Many affected individuals developed early-onset osteoarthritis and degenerative disc disease, suggesting dysfunction of the articular cartilage and intervertebral disc cartilage. Additional studies are needed to determine the optimal treatment strategy for these patients.
Center for Personalized Medicine Children's Hospital of Los Angeles Los Angeles California 90027
Cottage Children's Medical Center Santa Barbara California 93111
Department of Medical Sciences Örebro University and University Hospital Örebro 70185 Sweden
Department of Pediatrics Oregon Health and Science University Portland Oregon 97239
Departments of Molecular and Human Genetics and
Division of Endocrinology Phoenix Children's Hospital Phoenix Arizona 85016
Division of Genetics Washington University St Louis Missouri 63130
Division of Pediatric Endocrinology Connecticut Children's Medical Center Hartford Connecticut 06106
Divisions of Endocrinology and
El Rio Community Health Center Tucson Arizona 85745
Genetics Boston Children's Hospital Boston Massachusetts 02115
Hasbro Children's Hospital Providence Rhode Island 02903
Pediatric Endocrinology and Metabolism Baylor College of Medicine Houston Texas 77030
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19013190
- 003
- CZ-PrNML
- 005
- 20190416074904.0
- 007
- ta
- 008
- 190405s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1210/jc.2016-3313 $2 doi
- 035 __
- $a (PubMed)27870580
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gkourogianni, Alexandra $u Division of Pediatric Endocrinology, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, Stockholm SE-171 76, Sweden.
- 245 10
- $a Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations / $c A. Gkourogianni, M. Andrew, L. Tyzinski, M. Crocker, J. Douglas, N. Dunbar, J. Fairchild, MF. Funari, KE. Heath, AA. Jorge, T. Kurtzman, S. LaFranchi, S. Lalani, J. Lebl, Y. Lin, E. Los, D. Newbern, C. Nowak, M. Olson, J. Popovic, Š. Pruhová, L. Elblova, JB. Quintos, E. Segerlund, L. Sentchordi, M. Shinawi, EL. Stattin, J. Swartz, AG. Angel, SD. Cuéllar, H. Hosono, PA. Sanchez-Lara, V. Hwa, J. Baron, O. Nilsson, A. Dauber,
- 520 9_
- $a Context: Heterozygous mutations in the aggrecan gene (ACAN) cause autosomal dominant short stature with accelerated skeletal maturation. Objective: We sought to characterize the phenotypic spectrum and response to growth-promoting therapies. Patients and Methods: One hundred three individuals (57 females, 46 males) from 20 families with autosomal dominant short stature and heterozygous ACAN mutations were identified and confirmed using whole-exome sequencing, targeted next-generation sequencing, and/or Sanger sequencing. Clinical information was collected from the medical records. Results: Identified ACAN variants showed perfect cosegregation with phenotype. Adult individuals had mildly disproportionate short stature [median height, -2.8 standard deviation score (SDS); range, -5.9 to -0.9] and a history of early growth cessation. The condition was frequently associated with early-onset osteoarthritis (12 families) and intervertebral disc disease (9 families). No apparent genotype-phenotype correlation was found between the type of ACAN mutation and the presence of joint complaints. Childhood height was less affected (median height, -2.0 SDS; range, -4.2 to -0.6). Most children with ACAN mutations had advanced bone age (bone age - chronologic age; median, +1.3 years; range, +0.0 to +3.7 years). Nineteen individuals had received growth hormone therapy with some evidence of increased growth velocity. Conclusions: Heterozygous ACAN mutations result in a phenotypic spectrum ranging from mild and proportionate short stature to a mild skeletal dysplasia with disproportionate short stature and brachydactyly. Many affected individuals developed early-onset osteoarthritis and degenerative disc disease, suggesting dysfunction of the articular cartilage and intervertebral disc cartilage. Additional studies are needed to determine the optimal treatment strategy for these patients.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a agrekany $x genetika $7 D053674
- 650 _2
- $a antropometrie $x metody $7 D000886
- 650 _2
- $a brachydaktylie $x genetika $7 D059327
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a mutační analýza DNA $x metody $7 D004252
- 650 _2
- $a nanismus $x farmakoterapie $x genetika $7 D004392
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a růst $x genetika $7 D006128
- 650 _2
- $a růstový hormon $x terapeutické užití $7 D013006
- 650 _2
- $a heterozygot $7 D006579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a degenerace meziobratlové ploténky $x genetika $7 D055959
- 650 _2
- $a výhřez meziobratlové ploténky $x genetika $7 D007405
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a osteochondritis dissecans $x vrozené $x genetika $7 D010008
- 650 _2
- $a rodokmen $7 D010375
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Andrew, Melissa $u Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 70941.
- 700 1_
- $a Tyzinski, Leah $u Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 70941.
- 700 1_
- $a Crocker, Melissa $u Divisions of Endocrinology and.
- 700 1_
- $a Douglas, Jessica $u Genetics, Boston Children's Hospital, Boston, Massachusetts 02115.
- 700 1_
- $a Dunbar, Nancy $u Division of Pediatric Endocrinology, Connecticut Children's Medical Center, Hartford, Connecticut 06106.
- 700 1_
- $a Fairchild, Jan $u Department of Endocrinology and Diabetes, Women's and Children's Hospital, North Adelaide, South Australia 5006, Australia.
- 700 1_
- $a Funari, Mariana F A $u Unidade de Endocrinologia do Desenvolvimento (LIM/42), Disciplina de Endocrinologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo 05508-020, Brazil.
- 700 1_
- $a Heath, Karen E $u Institute of Medical and Molecular Genetics (INGEMM) and Skeletal Dysplasia Multidisciplinary Unit, Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, and CIBERER, ISCIII, Madrid 20849, Spain.
- 700 1_
- $a Jorge, Alexander A L $u Unidade de Endocrinologia do Desenvolvimento (LIM/42), Disciplina de Endocrinologia, Faculdade de Medicina da Universidade de São Paulo, São Paulo 05508-020, Brazil.
- 700 1_
- $a Kurtzman, Tracey $u El Rio Community Health Center, Tucson, Arizona 85745.
- 700 1_
- $a LaFranchi, Stephen $u Department of Pediatrics, Oregon Health and Science University, Portland, Oregon 97239.
- 700 1_
- $a Lalani, Seema $u Departments of Molecular and Human Genetics and.
- 700 1_
- $a Lebl, Jan $u Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague and University Hospital in Motol, Prague 11636, Czech Republic.
- 700 1_
- $a Lin, Yuezhen $u Pediatric Endocrinology and Metabolism, Baylor College of Medicine, Houston, Texas 77030.
- 700 1_
- $a Los, Evan $u Department of Pediatrics, Oregon Health and Science University, Portland, Oregon 97239.
- 700 1_
- $a Newbern, Dorothee $u Division of Endocrinology, Phoenix Children's Hospital, Phoenix, Arizona 85016.
- 700 1_
- $a Nowak, Catherine $u Genetics, Boston Children's Hospital, Boston, Massachusetts 02115.
- 700 1_
- $a Olson, Micah $u Division of Endocrinology, Phoenix Children's Hospital, Phoenix, Arizona 85016.
- 700 1_
- $a Popovic, Jadranka $u Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15237.
- 700 1_
- $a Pruhová, Štepánka $u Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague and University Hospital in Motol, Prague 11636, Czech Republic.
- 700 1_
- $a Elblova, Lenka $u Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague and University Hospital in Motol, Prague 11636, Czech Republic.
- 700 1_
- $a Quintos, Jose Bernardo $u Hasbro Children's Hospital, Providence, Rhode Island 02903.
- 700 1_
- $a Segerlund, Emma $u Division of Pediatric Endocrinology, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, Stockholm SE-171 76, Sweden. Sunderby Hospital, Sunderby 95442, Sweden.
- 700 1_
- $a Sentchordi, Lucia $u Institute of Medical and Molecular Genetics (INGEMM) and Skeletal Dysplasia Multidisciplinary Unit, Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, and CIBERER, ISCIII, Madrid 20849, Spain. Department of Pediatrics, Hospital Universitario Infanta Sofia, Madrid 28703, Spain.
- 700 1_
- $a Shinawi, Marwan $u Division of Genetics, Washington University, St. Louis, Missouri 63130.
- 700 1_
- $a Stattin, Eva-Lena $u Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala 75236, Sweden.
- 700 1_
- $a Swartz, Jonathan $u Divisions of Endocrinology and.
- 700 1_
- $a Angel, Ariadna González Del $u Laboratorio de Biología Molecular, Departamento de Genética Humana, Instituto Nacional de Pediatría, Insurgentes-Cuicuilco, Coyoacán 04530, México.
- 700 1_
- $a Cuéllar, Sinhué Diaz $u Laboratorio de Biología Molecular, Departamento de Genética Humana, Instituto Nacional de Pediatría, Insurgentes-Cuicuilco, Coyoacán 04530, México.
- 700 1_
- $a Hosono, Hidekazu $u Cottage Children's Medical Center, Santa Barbara, California 93111.
- 700 1_
- $a Sanchez-Lara, Pedro A $u Center for Personalized Medicine, Children's Hospital of Los Angeles, Los Angeles, California 90027.
- 700 1_
- $a Hwa, Vivian $u Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 70941.
- 700 1_
- $a Baron, Jeffrey $u Section on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; and.
- 700 1_
- $a Nilsson, Ola $u Division of Pediatric Endocrinology, Department of Women's and Children's Health, Karolinska Institutet and Karolinska University Hospital, Stockholm SE-171 76, Sweden. Section on Growth and Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; and. Department of Medical Sciences, Örebro University and University Hospital, Örebro 70185, Sweden.
- 700 1_
- $a Dauber, Andrew $u Cincinnati Center for Growth Disorders, Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 70941.
- 773 0_
- $w MED00002582 $t The Journal of clinical endocrinology and metabolism $x 1945-7197 $g Roč. 102, č. 2 (2017), s. 460-469
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27870580 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190416074929 $b ABA008
- 999 __
- $a ok $b bmc $g 1392500 $s 1051495
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 102 $c 2 $d 460-469 $i 1945-7197 $m The Journal of clinical endocrinology and metabolism $n J Clin Endocrinol Metab $x MED00002582
- GRA __
- $a NV16-31211A $p MZ0
- LZP __
- $a Pubmed-20190405